By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Genoa Pharmaceuticals 

701 Pike Street
Suite 1500
Seattle  Washington  98101   U.S.A.
Phone: n/a Fax: n/a



Company News
Seattle's Genoa Pharma Banks $62 Million and Names a New CEO and CSO 5/15/2017 5:44:04 AM
Genoa Pharmaceuticals Receives Orphan-Drug Designation For Pirfenidone In The Inhaled Treatment Of Idiopathic Pulmonary Fibrosis (IPF) 8/5/2014 6:43:46 AM
Genoa Pharmaceuticals To Present At The Annual American Thoracic Society International Conference 5/13/2014 6:42:41 AM
Genoa Pharmaceuticals And McMaster University Demonstrate Inhaled Pharmacokinetics Enables Improved Pirfenidone Activity With Significant Promise To Enhance IPF Treatment Safety And Tolerability 4/21/2014 6:25:22 AM
Genoa Pharmaceuticals and McMaster University Demonstrate In Vivo Benefit of Inhaled Pirfenidone Offering Greater Pulmonary Fibrosis Efficacy Than Oral Therapy 6/5/2013 10:01:25 AM
Genoa Pharmaceuticals and McMaster University to Collaborate on Idiopathic Pulmonary Fibrosis Research 1/16/2013 9:11:26 AM
Genoa Pharmaceuticals Announces $1.2 Million Financing 11/8/2012 10:25:52 AM